A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease
Clinical trial NCT05063539 · COMPLETED
Trial details
- NCT number
- NCT05063539
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-16
- Primary completion
- 2024-07-09
- Enrollment
- 327
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.